CPT 0951T Middle Ear Implant Billing: The Full 5-Code ENT Guide for 2027

What Is CPT Code 0951T for Middle Ear Implants?

CPT 0951T is a Category III tracking code for the initial surgical placement of a totally implantable active middle ear hearing implant (AMEI), including mastoidectomy and attachment of the sound processor. It is one of five codes (0951T through 0955T) that together cover the complete implant lifecycle: initial placement, revision with and without mastoidectomy, sound processor replacement, and complete removal. These codes were added to the CPT code set for tracking emerging technology and apply to encounters in 2026 and 2027.

Five codes, one workflow: The 0951T through 0955T series separates each phase of the AMEI process into its own billable code. The distinction matters because each code describes a different scope of surgery, and reporting the wrong one misrepresents the work performed.

Category III designation: All five codes are Category III (temporary tracking) codes, not Category I. This means they track utilization of an emerging technology and often face limited or no payer coverage. ENT practices billing these codes should expect coverage challenges and plan for appeals.

What it includes: 0951T bundles the mastoidectomy, device implantation, and sound processor attachment into a single code. The mastoidectomy is not billed separately when performed as part of the implant placement.

The Five AMEI Codes Explained

The five codes cover every clinical scenario an ENT practice will encounter across the lifetime of a totally implantable active middle ear hearing implant. Here is what each code describes:

Code	Description	Mastoid-ectomy	Processor	Billable
0951T	Initial placement of totally implantable AMEI	Included	Included	Yes
0952T	Revision or replacement of AMEI	Included	Replaced	Yes
0953T	Revision or replacement of AMEI	Not included	Not replaced	Yes
0954T	Replacement of sound processor only	Not included	Replaced	Yes
0955T	Removal of all AMEI components	N/A	N/A	Yes

The critical distinction between 0952T and 0953T is whether the revision includes a mastoidectomy and sound processor replacement. 0952T is the larger procedure: it includes both. 0953T covers a revision or replacement that does not require reopening the mastoid or swapping the processor. Reporting 0952T when the actual procedure was a 0953T-level revision will overstate the work performed and creates an audit risk.

0954T stands apart from the rest because it covers only the sound processor component, not the implant itself. This is the code for a technology upgrade or processor failure where the existing transducers remain in place and only the processor is exchanged and reattached. It is a smaller procedure than 0951T through 0953T and carries a correspondingly lower RVU expectation.

0955T covers full device removal. This code applies when all components of the AMEI are explanted, whether due to device failure, patient preference, infection, or other clinical indication. It does not apply when only one component is removed and replaced, as that scenario falls under 0952T or 0953T depending on scope.

One question we hear constantly from practice managers at ENT groups considering implant programs is whether these codes can be billed alongside other otologic procedure codes like CPT 69436 (myringotomy). They cannot when performed in the same operative session on the same ear, because 0951T bundles the surgical access. If a myringotomy is performed on the contralateral ear during the same session, modifier 59 would apply, but this is a rare clinical scenario.

What Makes Category III Codes Different for Billing

Category III CPT codes are temporary codes assigned to emerging technologies, services, and procedures. They track utilization data that the AMA and CMS use to evaluate whether a procedure should eventually receive a permanent Category I code. The 0951T through 0955T series sits in this category because totally implantable AMEIs are still considered emerging technology by payer standards, even though the devices have been in clinical use for years.

The billing consequence is significant: many payers do not have established coverage policies for Category III codes. Medicare typically does not assign RVUs to Category III codes through the standard Physician Fee Schedule, which means payment, if it happens at all, is handled through individual carrier pricing or negotiated rates. Commercial payers vary widely. Some will process Category III codes at a contracted rate, some will deny as experimental or investigational, and some will require a prior authorization pathway that does not exist in their standard authorization system.

Across the billing companies we vet for ENT practices, the ones that handle implant billing successfully share one pattern: they verify coverage and obtain prior authorization before the procedure, not after. A denial on a Category III code after the surgery is far harder to overturn than a pre-service authorization. The Modifier 25 payment changes for 2027 and the UHC prior authorization changes for ENT procedures add to the complexity of managing these claims within the current payer landscape.

The most common issue we see providers run into is assuming that because a device has FDA clearance, payers will cover the implant procedure. FDA clearance and payer coverage are entirely separate determinations. An AMEI device can be FDA-cleared and still be classified as experimental by a payer’s medical policy committee, which means the 0951T claim will deny regardless of clinical documentation quality.

What Documentation Supports 0951T Through 0955T

Each code in the series requires documentation that establishes the clinical indication for the procedure, the specific components involved, and the scope of the surgery performed. The documentation must support the specific code billed, not just the fact that an implant procedure occurred.

For 0951T (initial placement), the operative report should document the mastoidectomy approach, the implant device and manufacturer, the placement of transducers, the attachment of the sound processor, and intraoperative functional testing. The preoperative record should establish the clinical indication, typically sensorineural or mixed hearing loss in a patient who is not adequately served by conventional hearing aids, supported by comprehensive audiometric evaluation (CPT 92557) results.

For 0952T and 0953T (revisions), the documentation must clearly state whether the procedure included a mastoidectomy and whether the sound processor was replaced. This is the detail that determines which of the two codes is correct. A revision that accessed the mastoid and replaced the processor is 0952T. A revision that did not require either is 0953T. If the operative report is ambiguous on these points, the claim is at risk for a documentation-based denial or a downcode to 0953T.

For 0954T (processor replacement), document that only the sound processor was exchanged, that the existing transducers were confirmed functional and left in place, and that the replacement processor was successfully attached and tested. For 0955T (complete removal), document the removal of all implant components and the clinical reason for explantation.

In our experience matching ENT practices with billing partners, the documentation gap that causes the most claim problems on implant procedures is the operative report that describes what was done but not why each component was addressed. Payers reviewing high-dollar implant claims want to see clinical reasoning, not just surgical narration.

Which ICD-10 Codes Support AMEI Procedures

The primary diagnosis codes that support medical necessity for a totally implantable middle ear hearing implant are sensorineural and mixed hearing loss codes. The most commonly paired ICD-10-CM codes include:

ICD-10-CM Code	Description	Use With
H90.3	Sensorineural hearing loss, bilateral	0951T, 0952T-0955T
H90.41/H90.42	Sensorineural hearing loss, unilateral	0951T, 0952T-0955T
H90.6	Mixed conductive and sensorineural hearing loss, bilateral	0951T, 0952T-0955T
H90.71/H90.72	Mixed hearing loss, unilateral	0951T, 0952T-0955T
T85.39XA	Mechanical complication of other ocular prosthetic devices, implants and grafts, initial encounter	0952T, 0953T, 0955T
Z96.21	Cochlear implant status	Supplementary (if applicable)

For revisions (0952T, 0953T) and removals (0955T), the diagnosis code should reflect the reason for the secondary procedure: device malfunction (T85 codes), infection (T85.79XA with the appropriate infection code), or clinical deterioration. For processor replacements (0954T), device failure or technology upgrade is the typical indication. The ICD-10-CM code must match the clinical scenario to support medical necessity. For a broader reference on ENT diagnosis coding, see the ENT ICD-10 and CPT code guide.

Providers often come to us after a payer denies an implant claim for lack of medical necessity, and the root cause is almost always the diagnosis code. An H90.3 (bilateral sensorineural hearing loss) paired with 0951T is a defensible claim. An H91.90 (unspecified hearing loss, unspecified ear) paired with the same procedure code invites a denial because the diagnosis does not establish the severity or laterality that justifies an implant.

Common Billing Mistakes With AMEI Codes

The 0951T series is new enough and niche enough that most ENT billing teams encounter these codes infrequently. That infrequency is where the mistakes come from.

Billing the mastoidectomy separately from 0951T or 0952T. Both of these codes include the mastoidectomy as part of the bundled procedure. Reporting a separate mastoidectomy code (such as CPT 69210 for a different ear procedure or 69505 for a mastoidectomy) alongside 0951T or 0952T will trigger a bundling edit and a denial on the mastoidectomy line.

Confusing 0952T and 0953T. If the revision included a mastoidectomy and processor replacement, report 0952T. If it did not, report 0953T. The operative report must state this clearly. A claim submitted with 0952T when the actual procedure was a 0953T-level revision is an overcoding risk.

Failing to obtain prior authorization. Category III codes are high-denial targets precisely because many payers lack standard coverage policies for them. Skipping prior authorization because “the payer does not have a policy” is not the same as “the payer will pay.” Contact the payer’s medical policy department directly, request a coverage determination, and get the authorization in writing before the procedure date.

Using nonspecific hearing loss diagnosis codes. H91.90 (unspecified hearing loss, unspecified ear) does not support the medical necessity of an implant that requires confirmed sensorineural or mixed hearing loss in a specific ear. Use the most specific H90 code the documentation supports.

Not submitting the device invoice with the claim. Many payers processing Category III implant codes require the device invoice or a manufacturer letter of medical necessity as part of the claim package. Submitting the professional claim without the device documentation delays adjudication and often triggers a request for additional information that adds weeks to the payment timeline. Across the billing companies we vet, the ones that close these claims fastest are the ones that attach the device documentation on the initial submission, not on the appeal. This is the same kind of proactive documentation approach that prevents the common ENT billing mistakes we see on more routine claims.

Frequently Asked Questions

Next Steps

New to ENT billing codes? Start with the ENT CPT and ICD-10 code guide for the foundational codes your practice reports most often.

Billing other ear procedures? See the CPT 69436 myringotomy billing guide and the CPT 92557 audiometry overview for the ear codes your practice already uses.

Watching 2027 billing changes? See the FY 2027 ICD-10-CM ENT update and the Modifier 25 payment cut for ENT for changes that affect the same claims.

Need help with high-dollar implant billing? Get matched with vetted ENT billing companies that know how to navigate Category III coverage and close these claims on the first submission.